Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tobii (formerly operating its research arm as Tobii Pro) is the global leader in eye-tracking technology, providing advanced hardware and software solutions for scientific research, clinical diagnostics, and commercial applications. The company's technology is extensively used in the life sciences to study neurodevelopmental and neurodegenerative disorders by capturing high-precision data on eye movements and pupil dilation. Their product portfolio includes high-frequency screen-based trackers, wearable eye-tracking glasses, and comprehensive analytics software like Tobii Pro Lab. These tools enable researchers to gain objective, non-invasive insights into human cognition, attention, and emotion. Tobii's solutions are integrated into clinical workflows for early detection of conditions such as autism and Alzheimer's disease. Headquartered in Sweden, the company serves thousands of academic institutions and enterprise clients worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tobii Pro.